Joana Tavares-Brito1,2, Martinus M van Veen1,3, Joseph R Dusseldorp1,4, Fayez Bahmad2, Tessa A Hadlock1. 1. Facial Nerve Center, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary and Harvard Medical School, Boston, Massachusetts, U.S.A. 2. Healthy Science School, University of Brasilia, Brasilia, Brazil. 3. Department of Plastic Surgery, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands. 4. Department of Plastic and Reconstructive Surgery, Royal Australasian College of Surgeons and University of Sydney, Sydney, Australia.
Abstract
OBJECTIVES: To investigate the correlation between facial palsy severity and quality of life in a broad cohort of facial palsy patients and to elucidate factors that influence this relationship. STUDY DESIGN: Retrospective study. METHODS: Records of patients presenting with a clinician-graded facial function (eFACE) and facial palsy-specific quality-of-life patient-reported outcome measure (FaCE) scale from the same moment were reviewed. Multiple linear regression was performed to study the effect of various variables on FaCE total score. RESULTS: A total of 920 of 1,304 patients were included, 59.9% female with a mean (standard deviation) age of 48.6 (16.7) years and a median (interquartile range palsy duration of 9.6 [2.2; 42.2] months. A multiple linear regression model predicting FaCE total score was established, finding 10 significant variables: eFACE; viral, malignant, and congenital etiologies; overweight status; anxiety; chronic pain; previous treatment; radiotherapy; and duration of palsy (R2 = 0.261, P < 0.001). Gender, age, laterality, surgical etiology, depression, and timing of evaluation (at initial intake or at follow up) were not found to predict FaCE total scores. CONCLUSION: A correlation between facial palsy severity and quality of life was found in a large cohort of patients comprising various etiologies. Additionally, novel factors that predict quality of life in facial palsy were revealed. This information may help specialists to predict which facial palsy patients are at higher risk of a poorer quality of life, regardless of severity. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:100-104, 2019.
OBJECTIVES: To investigate the correlation between facial palsy severity and quality of life in a broad cohort of facial palsypatients and to elucidate factors that influence this relationship. STUDY DESIGN: Retrospective study. METHODS: Records of patients presenting with a clinician-graded facial function (eFACE) and facial palsy-specific quality-of-life patient-reported outcome measure (FaCE) scale from the same moment were reviewed. Multiple linear regression was performed to study the effect of various variables on FaCE total score. RESULTS: A total of 920 of 1,304 patients were included, 59.9% female with a mean (standard deviation) age of 48.6 (16.7) years and a median (interquartile range palsy duration of 9.6 [2.2; 42.2] months. A multiple linear regression model predicting FaCE total score was established, finding 10 significant variables: eFACE; viral, malignant, and congenital etiologies; overweight status; anxiety; chronic pain; previous treatment; radiotherapy; and duration of palsy (R2 = 0.261, P < 0.001). Gender, age, laterality, surgical etiology, depression, and timing of evaluation (at initial intake or at follow up) were not found to predict FaCE total scores. CONCLUSION: A correlation between facial palsy severity and quality of life was found in a large cohort of patients comprising various etiologies. Additionally, novel factors that predict quality of life in facial palsy were revealed. This information may help specialists to predict which facial palsypatients are at higher risk of a poorer quality of life, regardless of severity. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:100-104, 2019.
Authors: Tessa E Bruins; Martinus M van Veen; Tanja Mooibroek-Leeuwerke; Paul M N Werker; Dieuwke C Broekstra; Pieter U Dijkstra Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-04-01 Impact factor: 6.223
Authors: Daniele Starnoni; Lorenzo Giammattei; Giulia Cossu; Michael J Link; Pierre-Hugues Roche; Ari G Chacko; Kenji Ohata; Majid Samii; Ashish Suri; Michael Bruneau; Jan F Cornelius; Luigi Cavallo; Torstein R Meling; Sebastien Froelich; Marcos Tatagiba; Albert Sufianov; Dimitrios Paraskevopoulos; Idoya Zazpe; Moncef Berhouma; Emmanuel Jouanneau; Jeroen B Verheul; Constantin Tuleasca; Mercy George; Marc Levivier; Mahmoud Messerer; Roy Thomas Daniel Journal: Acta Neurochir (Wien) Date: 2020-07-29 Impact factor: 2.216
Authors: Amir J Khan; Ala Szczepura; Shea Palmer; Chris Bark; Catriona Neville; David Thomson; Helen Martin; Charles Nduka Journal: Clin Rehabil Date: 2022-07-05 Impact factor: 2.884
Authors: Sina Kim; Hye-Yoon Lee; Nam-Kwen Kim; Tae Han Yook; Eun-Sung Seo; Jong Uk Kim Journal: Health Qual Life Outcomes Date: 2018-11-19 Impact factor: 3.186